Yi Ching Y.
About Yi Ching Y.
Yi Ching Y. serves as the Chief Accounting Officer at BridgeBio in Palo Alto, California, a position she has held since 2019. She has extensive experience in finance and accounting, having previously worked in various roles at Theravance Biopharma, Nektar Therapeutics, and Ernst & Young.
Work at BridgeBio
Yi Ching Y. has held the position of Chief Accounting Officer at BridgeBio since 2019. In this role, she oversees the company's accounting operations and financial reporting. Her tenure at BridgeBio, located in Palo Alto, California, has spanned five years, during which she has contributed to the financial management and strategic planning of the organization.
Education and Expertise
Yi Ching Y. studied at Nanyang Technological University from 1996 to 1999, completing a three-year program. This educational background has provided her with a solid foundation in accounting and finance, which she has applied throughout her professional career.
Background
Prior to her current role at BridgeBio, Yi Ching Y. worked at Theravance Biopharma, Inc. as Corporate Controller from 2013 to 2018. She also served as VP Finance at Nektar Therapeutics for one year, from 2018 to 2019. Her career began at Ernst & Young LLP, where she worked as an Audit Senior Manager for 13 years, from 2000 to 2013.
Professional Experience
Yi Ching Y. has extensive experience in finance and accounting across multiple organizations. At Theravance Biopharma, she held the position of Corporate Controller, where she managed financial reporting and compliance. Her role as VP Finance at Nektar Therapeutics involved overseeing financial operations. Her long tenure at Ernst & Young LLP equipped her with significant expertise in auditing and financial advisory services.